Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-κB activation: Common genetic etiology with Blau syndrome

Blood

Volumn 105, Issue 3, 2005, Pages 1195-1197

  Kanazawa, Nobuo ^a   Okafuji, Ikuo ^b   Kambe, Naotomo ^b   Nishikomori, Ryuta ^b   Nakata Hizume, Mami ^b   Nagai, Sonoko ^b   Fuji, Akihiko ^b   Yuasa, Takenosuke ^b   Manki, Akira ^b   Sakurai, Yoshihiko ^b   Nakajima, Mitsuru ^b   Kobayashi, Hiroko ^b   Fujiwara, Ikuma ^b   Tsutsumi, Hiroyuki ^b   Utani, Atsushi ^b   Nishigori, Chikako ^b   Heike, Toshio ^b   Nakahata, Tatsutoshi ^b   Miyachi, Yoshiki ^b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADOLESCENT; ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLAU SYNDROME; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; JAPAN; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN VARIANT; SARCOIDOSIS;

EID: 19944431022     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-07-2972     Document Type: Article

References (25)

1. Shetty AK, Gedalia A. Sarcoidosis: a pediatric perspective. Clin Pediatr (Phila). 1998;37:707-717.
2. Fink CW, Cimaz R. Early onset sarcoidosis: not a benign disease. J Rheumatol. 1997;24:174-177.
3. Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107:689-693.
4. Tramp G, Kuivaniemi H, Raphael S, et al. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet. 1996;59:1097-1107.
5. Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet. 2001;29:19-20.
6. Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J Biol Chem. 2001;276:4812-4818.
7. Inohara N, Nunez Q. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 2003;3:371-382.
8. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603.
9. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411:603-606.
10. Rahman P, Bartlett S, Siannis F, et al. CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet. 2003;73:677-681.
11. Wang X, Kuivaniemi H, Bonavita G, et al. CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheum. 2002;46:3041-3045.
12. Kurokawa T, Kikuchi T, Ohta K, et al. Ocular manifestations in Blau syndrome associated with a CARD15/Nod2 mutation. Ophthalmology. 2003;110:2040-2044.
13. Miller JJ. Early-onset "sarcoidosis" and "familial granulomatous arthritis (arteritis)": the same disease. J Pediatr. 1986;109:387-388.
14. James G. Blau's syndrome and sarcoidosis. Lancet. 1999;354:1035.
15. Kanazawa N, Matsushima S, Kambe N, Tachibana T, Nagai S, Miyachi Y. Presence of a sporadic case of systemic granulomatosis syndrome wifh a CARD15 mutation. J Invest Dermatol. 2004;122:851-852.
16. Sakurai Y, Nakajima M, Kamisue S, et al. Preschool sarcoidosis mimicking juvenile rheumatoid arthritis: the significance of gallium scintigraphy and skin biopsy in the different diagnosis. Acta Paediatrica Japonica. 1997;39:74-78.
17. Shimomura Y, Tada R, Yamamoto Y, Yuasa T. Ocular sarcoidosis in a 7-year-old child. Jap J Clin Ophthalmol. 1982;36:109-112.
18. Akiyama H, Seno A, Tada J, Arata J, Oda M. Sarcoidosis in a 6-month-old infant - report of a case and review of the literature. Jap J Dermatol. 1993;103:19-25.
19. Ukae S, Tsutsumi H, Adachi N, Takahashi H, Kato F, Chiba S. Preschool sarcoidosis manifesting as juvenile rheumatoid arthritis: a case report and a review of the literature of Japanese cases. Acta Paediatrica Japonica. 1994;36:515-518.
20. Ito S, Kato R, Asano Y, et al. A child case of sarcoidosis presenting hepatosplenomegaly. Pediatr Jap. 1977;18:613-619.
21. Lesage S, Zouali H, Cezard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70:845-857.
22. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn's disease. J Biol Chem. 2003;278:5509-5512.
23. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869-8872.
24. Chamaillard M, Philpott D, Girardin SE, et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A. 2003;100:3455-3460.
25. Tanabe T, Chamaillard M, Ogura Y, et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 2004;23:1587-1597.